bioAffinity Technologies (BIAF) Interest & Investment Income (2021 - 2026)
bioAffinity Technologies (BIAF) reported Interest & Investment Income of $10026.0 for Q1 2026, up 1749.82% year-over-year from $542.0 in Q1 2025, and down 49.18% quarter-over-quarter from $19730.0 in Q4 2025.
bioAffinity Technologies (BIAF) Interest & Investment Income (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has 6 years of Interest & Investment Income data on file, last reported at $10026.0 in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $10026.0, up 1749.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $32869.0 (up 173.34% YoY), and the FY2025 annual result was $23385.0, up 32.79% from the prior year.
- Interest & Investment Income retreated to $10026.0 in Q1 2026 per BIAF's latest filing, from $19730.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $44124.0 in Q2 2023 and troughed at $276.0 in Q2 2022.
- A 5-year average of $13705.6 and a median of $6770.5 in 2022 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2024: Interest & Investment Income soared 38921.05% in 2022, then slumped 91.81% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at $38447.0 in 2022, then slumped by 68.37% to $12160.0 in 2023, then tumbled by 66.54% to $4069.0 in 2024, then soared by 384.89% to $19730.0 in 2025, then sank by 49.18% to $10026.0 in 2026.
- Business Quant data shows BIAF's Interest & Investment Income at $10026.0 in Q1 2026, $19730.0 in Q4 2025, and $1088.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 6.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 233.00 Mn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 27.00 Mn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 597,000.00 |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 13.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 10.00 Mn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | - |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 11.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | - |
| 10 | bioAffinity Technologies | 2.04 Mn | -1.06 Mn | - | 10,026.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,026.00 |
| Dec 31, 2025 | 19,730.00 |
| Sep 30, 2025 | 1,088.00 |
| Jun 30, 2025 | 2,025.00 |
| Mar 31, 2025 | 542.00 |
| Dec 31, 2024 | 4,069.00 |
| Sep 30, 2024 | 2,228.00 |
| Jun 30, 2024 | 5,186.00 |
| Mar 31, 2024 | 6,127.00 |
| Dec 31, 2023 | 12,160.00 |
| Sep 30, 2023 | 27,193.00 |
| Jun 30, 2023 | 44,124.00 |
| Mar 31, 2023 | 38,654.00 |
| Dec 31, 2022 | 38,447.00 |
| Sep 30, 2022 | 7,414.00 |
| Jun 30, 2022 | 276.00 |
| Dec 31, 2021 | 400.00 |
| Sep 30, 2021 | 19.00 |